Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

159.58

+3.77 (2.42%)

At close: Oct 20, 2026, 4:00 PM EDT

163.01

+3.43 (2.15%)

Pre-market: Oct 21, 2026, 4:00 AM EDT

Axsome Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,359	9,207	4,100	3,766	3,349	1,424
Market Cap Growth	30.93%	124.55%	8.88%	12.44%	135.22%	-53.20%
Enterprise Value	8,264	9,101	3,965	3,535	3,216	1,359
Last Close Price	159.58	182.64	84.61	79.59	77.13	37.78

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	10.76	14.42	10.63	13.92	66.94	-
PB Ratio	100.19	104.28	71.92	19.72	30.57	91.10
P/TBV Ratio	246.55	257.66	-	29.97	84.61	91.10

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	10.64	14.25	10.28	13.06	64.28	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	2.70	2.47	3.38	0.98	0.86	3.18
Net Debt / Equity Ratio	-1.14	-1.19	-2.15	-1.05	-0.97	-2.35
Net Debt / EBITDA Ratio	0.55	0.65	0.50	1.14	0.62	0.30
Net Debt / FCF Ratio	1.32	1.12	0.95	1.37	0.91	0.34
Asset Turnover	1.11	1.01	0.67	0.59	0.24	-
Inventory Turnover	1.87	2.17	2.16	2.68	-	-
Quick Ratio	1.30	1.45	1.99	3.46	2.47	3.75
Current Ratio	1.43	1.56	2.11	3.63	2.54	3.75
Return on Equity (ROE)	-245.10%	-252.12%	-231.63%	-159.21%	-298.97%	-201.51%
Return on Assets (ROA)	-16.31%	-16.81%	-27.28%	-24.86%	-52.30%	-56.91%
Return on Capital Employed (ROCE)	-60.70%	-54.40%	-74.60%	-40.70%	-74.70%	-192.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-2.29%	-1.99%	-7.00%	-6.35%	-5.59%	-9.16%
FCF Yield	-0.86%	-1.02%	-3.14%	-3.87%	-3.50%	-7.62%
Buyback Yield / Dilution	-4.44%	-3.82%	-5.48%	-11.73%	-8.07%	-1.11%

SEC Filings: 10-K · 10-Q